M&T Bank Corp Reata Pharmaceuticals Inc Transaction History

M&T Bank Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$25.61 - $110.96 $105,513 - $457,155	-4,120 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$100.0 - $143.02 $4,300 - $6,149	-43 Reduced 1.03%	4,120 $415,000
Q2 2021 Aug 13, 2021	SELL	$78.27 - $151.29 $33,186 - $64,146	-424 Reduced 9.24%	4,163 $589,000
Q1 2021 May 06, 2021	SELL	$94.25 - $132.81 $117,529 - $165,614	-1,247 Reduced 21.37%	4,587 $457,000
Q4 2020 Feb 12, 2021	BUY	$102.03 - $184.62 $5,815 - $10,523	57 Added 0.99%	5,834 $721,000
Q3 2020 Nov 06, 2020	SELL	$93.53 - $163.34 $35,073 - $61,252	-375 Reduced 6.1%	5,777 $562,000
Q2 2020 Jul 29, 2020	BUY	$126.3 - $176.56 $366,522 - $512,377	2,902 Added 89.29%	6,152 $960,000
Q1 2020 May 14, 2020	SELL	$124.16 - $247.74 $31,040 - $61,935	-250 Reduced 7.14%	3,250 $469,000
Q3 2019 Nov 12, 2019	SELL	$71.26 - $95.75 $641 - $861	-9 Reduced 0.26%	3,500 $281,000
Q2 2019 Aug 12, 2019	BUY	$77.72 - $94.35 $19,430 - $23,587	250 Added 7.67%	3,509 $331,000
Q1 2019 May 15, 2019	BUY	$51.9 - $101.79 $169,142 - $331,733	3,259 New	3,259 $279,000
Q4 2018 Feb 01, 2019	SELL	$48.76 - $76.44 $121,900 - $191,100	-2,500 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$35.64 - $92.06 $89,100 - $230,150	2,500 New	2,500 $204,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.